CCR5 is expressed in over 50% of all breast cancer
Post# of 145190
![](/assets/46931549/no_avatar_available_thumb.jpg)
Dr Pestell pick of TNBC for our studies is because about 97% of those patients expressing CCR5 , and cancer is very deadly .
But when approved , it will be given to any other breast cancer when cancer cells will be CCR5 positive.
And it will be used with other medicine , it is not a competition with them , but it will be use together for those patients....
![Like This Post](/images/thumb-up.png)
![Dislike This Post](/images/thumb-down.png)